Ozempic vs Foundayo

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Ozempic vs Foundayo: Overview

Choosing between Ozempic and Foundayo for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Ozempic focuses on semaglutide at $349/month with a rating of 8.9/10. Foundayo offers orforglipron at $149/month with a 9.2/10 rating.

The price difference of $200/month is significant - Foundayo is the more budget-friendly option, while Ozempic positions itself as a premium service.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$200/mo
Rating Difference
0.3
Winner
Foundayo
Best For
Budget

Ozempic

View full Ozempic review →
Rating
8.9/10
Monthly Price
$349
Medications
semaglutide

Pros

  • FDA-approved for type 2 diabetes
  • Weekly injection
  • Effective for weight loss (~10-15%)
  • Widely available
  • Often covered by insurance for diabetes

Cons

  • Approved for diabetes, not weight loss
  • Requires prescription
  • GI side effects common
  • May be prescribed off-label for weight loss
Choose Ozempic

Foundayo

View full Foundayo review →
Rating
9.2/10Better
Monthly Price
$149Cheaper
Medications
orforglipron

Pros

  • The first and only FDA-approved GLP-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 April 2026
  • In the ATTAIN-1 trial, participants on the highest dose who stayed on treatment lost an average of 27.3 pounds (12.4% of body weight) against 2.2 pounds (0.9%) on placebo
  • Counting everyone randomised regardless of whether they finished, the average was still 25 pounds (11.1%) versus 5.3 pounds (2.1%) on placebo - Lilly published both numbers rather than only the flattering one
  • A once-daily tablet, so there is no injection, no needle disposal and no refrigeration to organise
  • Self-pay pricing is published up front at $149 per month for the lowest dose through LillyDirect, with free home delivery
  • Eligible people with commercial insurance may pay as little as $25 per month with the Foundayo savings card
  • Eligible Medicare Part D patients may be able to get it for $50 per month from as early as 1 July 2026 - a rarity in this category
  • Lilly reported reductions in waist circumference, non-HDL cholesterol, triglycerides and systolic blood pressure across all doses
  • It is a small-molecule (non-peptide) GLP-1, which is why it can be manufactured as a pill rather than an injection

Cons

  • Weight loss is meaningfully lower than the best injectables. 12.4% at the top dose sits below tirzepatide territory, so if maximum weight loss is the goal an injection still wins
  • It carries the class boxed warning: it may cause thyroid tumours including thyroid cancer, and must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2
  • Should not be used alongside another GLP-1 receptor agonist
  • Common side effects include nausea, constipation, diarrhoea, vomiting, indigestion, abdominal pain, headache, fatigue, heartburn, gas and hair loss
  • Serious risks in the label include pancreatitis, dehydration leading to kidney problems, gallbladder problems, severe allergic reactions and aspiration risk under anaesthesia
  • Safety and effectiveness in children have not been established
  • $149 is the price of the lowest dose only - higher doses cost more, and the $25 and $50 figures depend on insurance eligibility rather than being available to everyone
  • Very new to market, so there is no long-term real-world safety and adherence record yet
Choose Foundayo

Feature-by-feature comparison

FeatureOzempicFoundayo
Monthly Price$349$149
Rating8.9/109.2/10
Medicationssemaglutideorforglipron
Insurance AcceptedYesYes
Support HoursMon-Fri 8AM-8PM ETNot published
Live ChatNoNo
Free ShippingNoYes
Shipping SpeedVaries by pharmacyFree home delivery via LillyDirect; shipping began 6 April 2026
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyAs prescribed by physicianAs directed by your prescriber
Money-back GuaranteeSavings card available (as low as $25 for eligible patients)None published; this is a prescription medicine, not a subscription service
Cancellation PolicyPrescription-based, consult doctorPrescription-based - stopping treatment is a decision for you and your prescriber

Which should you choose?

Choose Ozempic if you:

  • Value: fda-approved for type 2 diabetes

Choose Foundayo if you:

  • Want to save $200/month with a more affordable option
  • Prefer a higher-rated service (9.2/10 vs 8.9/10)
  • Value: the first and only fda-approved glp-1 pill for weight loss that can be taken at any time of day with no food or water restrictions, approved 1 april 2026

Website previews

Ozempic

Ozempic website

Foundayo

Foundayo website

Our recommendation

Foundayo comes out ahead with a higher rating of 9.2/10.
Get started with Foundayo

Compare other providers

Compare GLP-1 Brands